Cargando…
Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report
There is no curative treatment for patients with diffuse intrinsic pontine glioma (DIPG). However, with the recent availability of biopsy and autopsy tissue, new data regarding the biologic behavior of this tumor have emerged, allowing greater molecular characterization and leading to investigations...
Autores principales: | Nazarian, Javad, Mason, Gary E., Ho, Cheng Ying, Panditharatna, Eshini, Kambhampati, Madhuri, Vezina, L. Gilbert, Packer, Roger J., Hwang, Eugene I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173175/ https://www.ncbi.nlm.nih.gov/pubmed/27329600 http://dx.doi.org/10.18632/oncotarget.10034 |
Ejemplares similares
-
Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report
por: Nazarian, Javad, et al.
Publicado: (2023) -
Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma
por: Nikbakht, Hamid, et al.
Publicado: (2016) -
Differential Expression of Wilms’ Tumor Protein in Diffuse Intrinsic Pontine Glioma
por: Lee, Sulgi, et al.
Publicado: (2019) -
The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma
por: Yadavilli, Sridevi, et al.
Publicado: (2015) -
DIPG-26. Targeted Protein Degradation of LSD1 synergizes with HDAC inhibitors in Diffuse Intrinsic Pontine Glioma
por: Groves, Andrew, et al.
Publicado: (2022)